Generalized Pustular Psoriasis (GPP) drugs in development, 2024

GlobalData tracks 6 drugs in development for Generalized Pustular Psoriasis (GPP) by five companies/universities/institutes. The top development phase for Generalized Pustular Psoriasis (GPP) is preclinical, with two drugs in that stage.

Good sleep patterns cut heart disease risk, study finds

Persistently favorable sleep patterns may reduce the risk of cardiovascular disease, even in individuals with higher genetic susceptibility.

April 26, 2024

Do lifestyle factors affect late-life cognition and dementia pathology impact?

Scientists from the Rush University Medical Center in Chicago, United States, investigated whether brain pathology related to dementia, such as cerebrovascular pathology, phosphorylated tau fibril

February 7, 2024

Reducing processed meat consumption could reduce burden of chronic diseases in the USA, study suggests

Researchers developed a microsimulation model, micro-Simulation of the Health Impacts of Food Transformations, to evaluate the impact of reducing processed and unprocessed meat intake on

July 8, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.